In:
Rheumatology & Autoimmunity, Wiley, Vol. 3, No. 1 ( 2023-03), p. 35-42
Abstract:
The prognosis of focal segmental glomerulosclerosis (FSGS) patients with nephrotic syndrome is poor. We investigated the effectiveness of treatment in 50 patients with primary FSGS. Low‐density lipoprotein‐apheresis (LDL‐A) was performed in four patients who presented with steroid‐resistant nephrotic syndrome. LDL‐A therapy tended to be chosen for more critical cases. Although it may be effective at improving the remission rate, we believe that studies on more patients are required to elucidate the effect on long‐term prognosis.
Type of Medium:
Online Resource
ISSN:
2767-1429
,
2767-1429
Language:
English
Publisher:
Wiley
Publication Date:
2023
detail.hit.zdb_id:
3100945-1
Bookmarklink